SCHEMBL8418007

SCHEMBL8418007

Clc1nc2ccccc2n1CCCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 9/20 0.54
DRD2 P14416 8/20 0.54
HTR7 P34969 7/20 0.54
HTR2A P28223 7/20 0.54
DRD4 P21917 4/20 0.54
DRD3 P35462 4/20 0.54
ADRA2A P08913 2/20 0.52
ADRA2C P18825 2/20 0.52
ADRA1A P35348 2/20 0.52
SLC6A2 P23975 1/20 0.52
HRH1 P35367 1/20 0.52
HTR2B P41595 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
GRM2 Q14416 5/20 0.50
DRD1 P21728 1/20 0.48
DRD5 P21918 1/20 0.48
HTR6 P50406 3/20 0.47
ABCB11 O95342 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416338 0.85 P2RX7 (0.63) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL8418064 0.78 HTR1A (0.59) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL8416308 0.78 P2RX7 (0.61) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL17192206 0.78 KCNH2 (0.64) HTR1AHTR7HTR2ADRD3HRH1
SCHEMBL28154146 0.77 LMNA (0.60) ALDH1A1CYP1A2CYP2C19LMNA
SCHEMBL8418073 0.76 DRD2 (0.70) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL17103028 0.76 LMNA (0.59) ALDH1A1LMNA
SCHEMBL15748175 0.75 SIGMAR1 (0.58) HTR1ADRD2HTR7HTR2ADRD3
SCHEMBL26492991 0.75 HTR1A (0.65) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL26108581 0.75 HTR1A (0.65) HTR1ADRD2HTR7HTR2ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed